HTTP/1.1 403 Forbidden
Server: awselb/2.0
Date: Wed, 26 Mar 2025 05:56:08 GMT
Content-Type: text/html
Content-Length: 520
Connection: keep-alive
SSL Certificate
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
ad:62:7b:75:f9:e7:cb:44:ad:cb:45:25:3b:8c:fe:fc
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=GB, ST=Greater Manchester, L=Salford, O=Sectigo Limited, CN=Sectigo RSA Organization Validation Secure Server CA
Validity
Not Before: Dec 11 00:00:00 2024 GMT
Not After : Dec 11 23:59:59 2025 GMT
Subject: C=US, ST=Delaware, O=AstraZeneca Pharmaceuticals LP, CN=cmops-dev.astrazeneca.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:b2:8d:bf:be:b4:a1:bc:fc:99:d7:98:0f:51:b1:
54:81:53:ae:e5:3c:6b:30:c4:7f:c7:59:9e:0f:0e:
3f:f4:55:2c:2a:20:e3:c3:44:a5:b7:89:ea:c5:34:
cb:d5:a9:2a:73:58:6c:98:f5:78:b6:53:fa:99:43:
d6:45:ed:f0:1b:ee:60:ab:4a:4e:5f:89:a3:96:df:
38:24:94:4c:96:21:e7:cf:e0:b9:4d:cb:32:5f:f9:
ae:a1:6d:91:d7:0b:f3:4a:8b:16:1d:95:0e:c3:00:
3c:cc:df:09:93:42:10:7d:f5:06:a1:31:eb:87:25:
56:b3:c1:c3:b4:88:20:62:1c:52:0e:04:39:80:04:
c2:e7:96:1a:a4:02:ac:d4:c0:74:b1:ba:1c:63:14:
8f:d4:c9:a1:99:63:d1:ac:fc:04:12:3e:34:74:e0:
7b:aa:f5:70:34:be:3b:d8:25:6d:62:6d:90:95:26:
7e:2a:ff:2d:ca:e1:7a:e0:27:7b:4a:a8:59:00:fc:
52:94:2e:6e:55:76:05:58:41:c4:6f:95:fa:96:8a:
da:96:fa:15:90:f0:cb:d2:de:26:de:0b:22:68:99:
01:f8:9b:b5:42:e4:ef:f7:e9:91:fe:6f:19:11:2c:
ff:7f:1e:12:0c:72:27:1b:a1:52:c8:fa:fd:c2:a3:
ef:37
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Authority Key Identifier:
17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB
X509v3 Subject Key Identifier:
57:E0:9B:33:06:58:6B:C7:CB:4A:10:F5:99:D9:19:68:A2:47:A7:1B
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Basic Constraints: critical
CA:FALSE
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Certificate Policies:
Policy: 1.3.6.1.4.1.6449.1.2.1.3.4
CPS: https://sectigo.com/CPS
Policy: 2.23.140.1.2.2
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl
Authority Information Access:
CA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt
OCSP - URI:http://ocsp.sectigo.com
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : DD:DC:CA:34:95:D7:E1:16:05:E7:95:32:FA:C7:9F:F8:
3D:1C:50:DF:DB:00:3A:14:12:76:0A:2C:AC:BB:C8:2A
Timestamp : Dec 11 14:46:31.170 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:14:95:82:5A:E4:31:BB:A9:EA:97:CD:36:
E9:08:1E:59:F6:77:28:AF:7B:10:90:C4:E7:8D:5E:89:
E1:9B:13:F8:02:20:22:62:34:46:16:04:8E:7B:01:2E:
77:DB:B0:64:2A:6E:EC:63:79:C5:11:6F:37:34:C8:FE:
83:F7:38:F1:50:04
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CC:FB:0F:6A:85:71:09:65:FE:95:9B:53:CE:E9:B2:7C:
22:E9:85:5C:0D:97:8D:B6:A9:7E:54:C0:FE:4C:0D:B0
Timestamp : Dec 11 14:46:31.133 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:46:02:21:00:F0:DF:6B:B6:7A:7E:D0:88:EA:44:74:
CF:78:0E:31:BD:69:8B:D2:6B:2D:0A:1B:99:73:3C:43:
63:4E:07:1A:8C:02:21:00:CB:0E:DD:59:A2:A0:E3:94:
58:31:0B:FC:3F:C7:69:05:0E:61:03:5C:3A:4F:66:DB:
70:46:A3:90:FD:A0:9F:B4
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 12:F1:4E:34:BD:53:72:4C:84:06:19:C3:8F:3F:7A:13:
F8:E7:B5:62:87:88:9C:6D:30:05:84:EB:E5:86:26:3A
Timestamp : Dec 11 14:46:31.057 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:52:C0:C3:74:B7:EE:78:EF:BA:9E:06:F4:
5A:3A:07:68:38:01:40:45:DF:BC:6E:B9:7B:65:10:A8:
C0:B3:4C:7A:02:20:39:09:AB:B3:23:37:7A:99:83:B2:
C3:43:C0:17:56:9A:D9:58:DB:E5:03:C5:C5:2E:4F:A8:
BD:46:BB:8E:E6:3F
X509v3 Subject Alternative Name:
DNS:cmops-dev.astrazeneca.com, DNS:apps.cmops-dev.astrazeneca.com, DNS:artifactory.cmops-dev.astrazeneca.com, DNS:bamboo.cmops-dev.astrazeneca.com, DNS:bitbucket.cmops-dev.astrazeneca.com, DNS:sonar.cmops-dev.astrazeneca.com, DNS:vault.cmops-dev.astrazeneca.com
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
42:0a:2e:dc:66:4e:d5:8f:64:7e:35:dc:05:9b:b3:9c:91:16:
eb:f6:aa:48:75:ac:c1:5a:32:2f:a4:6f:cb:00:97:68:30:ce:
56:cb:87:ed:74:95:2d:0d:03:7b:a7:7d:96:df:d0:45:0f:a0:
7e:e7:42:b0:21:34:70:5e:22:88:e9:13:33:34:be:e6:d4:84:
1c:69:32:a2:b6:65:1b:d3:79:ca:a9:79:66:96:0a:a5:71:b5:
28:87:e9:d7:48:fb:aa:4e:bc:a6:48:8a:35:60:97:26:e4:3e:
93:c9:ee:68:62:74:67:e7:89:47:a3:2e:1d:67:9c:c5:9f:e0:
55:e1:a8:88:5f:de:77:f5:ed:5a:61:0c:34:99:96:87:a8:fd:
53:9c:a4:d5:7c:f9:24:4e:77:77:ed:4c:63:00:ca:86:da:b7:
b9:fc:e9:22:4c:e2:9a:fd:8b:34:b7:89:dd:44:e3:f1:b3:a1:
67:cb:05:5b:54:3e:ae:f7:12:8a:da:9f:eb:4a:d0:8e:18:19:
ec:16:2d:bc:c7:97:90:86:5d:26:76:4b:95:1c:34:ae:a3:64:
4a:39:b6:d1:ba:dd:f8:53:60:ee:11:fd:b5:fa:25:73:fc:c5:
dd:a4:13:3c:83:02:69:1f:7f:4b:7f:b4:2a:75:45:b7:d4:4e:
04:1c:36:e5